本文選題：膽管癌 + 經(jīng)皮經(jīng)肝膽道引流��； 參考：《中國微創(chuàng)外科雜志》2017年08期

【摘要】：目的探討超細(xì)膽道鏡在經(jīng)皮經(jīng)肝膽管腫瘤活檢中的應(yīng)用價(jià)值。方法 2014年12月~2016年9月,對21例行經(jīng)皮經(jīng)肝膽道引流(percutaneous transhepatic cholangial drainage,PTCD)聯(lián)合膽道支架置入的膽管腫瘤,應(yīng)用超細(xì)膽道鏡取活檢。結(jié)果 10例獲得明確病理結(jié)果(腺癌),5例傾向于癌診斷,1例上皮內(nèi)瘤變,3例乳頭狀增生伴重度不典型增生,2例病理結(jié)果為炎癥。無嚴(yán)重并發(fā)癥。結(jié)論超細(xì)膽道鏡可以應(yīng)用于膽管腫瘤經(jīng)皮經(jīng)肝途徑活檢。
[Abstract]:Objective to evaluate the value of ultrafine choledochoscope in percutaneous transhepatic choledochal tumor biopsy. Methods from December 2014 to September 2016, 21 cases of cholangiocarcinoma underwent percutaneous transhepatic bile duct drainage (PTCD) combined with biliary stent implantation, and ultrafine choledochoscopy biopsy was performed. Results clear pathological results were obtained in 10 cases (5 cases of adenocarcinoma tended to be diagnosed as carcinoma 1 case of intraepithelial neoplasia 3 cases of papillary hyperplasia with severe atypical hyperplasia 2 cases of inflammation). There were no serious complications. Conclusion Superfine choledochoscopy can be used in percutaneous transhepatic biopsy of cholangiocarcinoma.
【作者單位】： 蚌埠醫(yī)學(xué)院第一附屬醫(yī)院肝膽外科;
【基金】：安徽省科技攻關(guān)基金(編號(hào):1501041155) 蚌埠醫(yī)學(xué)院科技發(fā)展基金(編號(hào):BYKF1404)
【分類號(hào)】：R735.8

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 費(fèi)圣賢;劉會(huì)春;孫U，

本文編號(hào)：1900956